Innovators. Dreamers. Industry Leaders.
Eutilogics, Inc. is a collection of people who are committed to improve health and well-being around the world. The core technology that Eutilogics employs for drug development is selecting targets that faithfully enhance or suppress human immune responses.
Our core technology is to employ human peripheral T lymphocytes as a therapeutic. We also have a series of immunomodulatory antibody therapeutics that are being developed to treat obesity and autoimmune diseases. Both T cell and antibody therapies are expected to produce powerful therapeutic activities with no or minimal toxicity.